Myomo (MYO) EBT Growth (3y) (2019 - 2025)
Myomo (MYO) EBT Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | 4.82% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | -2.57% |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 61.06% |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 32.11% |
| 10 | Myomo | 42.89 Mn | 23.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -7.92% |
| Jun 30, 2025 | -15.43% |
| Mar 31, 2025 | -6.72% |
| Dec 31, 2024 | 64.52% |
| Sep 30, 2024 | 24.33% |
| Jun 30, 2024 | 27.14% |
| Mar 31, 2024 | -8.57% |
| Dec 31, 2023 | -11.99% |
| Sep 30, 2023 | 10.61% |
| Jun 30, 2023 | 32.34% |
| Mar 31, 2023 | 11.87% |
| Dec 31, 2022 | 74.63% |
| Sep 30, 2022 | -0.22% |
| Jun 30, 2022 | -4.36% |
| Mar 31, 2022 | -1.77% |
| Dec 31, 2021 | 2.14% |
| Sep 30, 2021 | 9.10% |
| Jun 30, 2021 | 0.96% |
| Mar 31, 2021 | -6.87% |
| Dec 31, 2020 | 2.47% |